Results 211 to 220 of about 1,250,673 (409)

746 CpG Island Methylator Phenotype May Confer a Survival Benefit From Fluoropyrimidine-Based Adjuvant Chemotherapy on Patients With Stage II or III Colorectal Carcinomas

, 2010
Young Kyung Sung, Byung‐Hoon Min, Young Ho Kim, Dong Kyung Chang, Hee Cheol Kim, Cheol Keun Park, Kyoung‐Mee Kim   +6 more
openalex   +1 more source

Foliar absorption of pesticide in combination with adjuvants visualized through confocal laser scanning microscopy [PDF]

, 2016
Mora-Garcia, Chime, Spanoghe, Pieter
core   +1 more source

Bimetallic Nanoreactor Activates cGAS‐STING Pathway via mtDNA Release for Cancer Metalloimmunotherapy

Advanced Functional Materials, EarlyView.
A bimetallic Mn–Ca nanoreactor (MCC) is developed as a non‐nucleotide STING nanoagonist for cancer metalloimmunotherapy. MCC induces Ca2+ overload and hydroxyl radical generation, resulting in mitochondrial damage and mtDNA release. The released mtDNA cooperates with Mn2+ to robustly activate cGAS–STING signaling.
Xin Wang Mo, Nguyen Thi Nguyen, LiLi Guo, Ngoc Man Phan, Hyunsu Shin, Tae‐il Kim, Yu Seok Youn, Jaeyun Kim   +7 more
wiley   +1 more source

Adjuvant chemo-immunotherapy shows comparable efficacy among mismatch-repair-deficient and mismatch-repair-proficient stage III colon cancer: an exploratory, reconstructed individual patient-level data analysis. [PDF]

J Immunother Cancer
Chen YT, Wang R, Situ YT, Wang WF, Zhang W, Lin JZ, Peng J, Wang ZX.   +7 more
europepmc   +1 more source

The uncoupling effect of the nonsteroidal anti‐inflammatory drug nimesulide in liver mitochondria from adjuvant‐induced arthritic rats [PDF]

, 2001
Silvana Martins Caparroz‐Assef, Clairce Luzia Salgueiro‐Pagadigorria, Ciomar Aparecida Bersani‐Amado, Adelar Bracht, Ana Maria Kelmer‐Bracht, Emy Luiza Ishii‐Iwamoto   +5 more
openalex   +1 more source

Synergistic Compatibilization of CsPbBr3 Perovskites and HfO2 Nanocrystals for Hybrid Sensitized Nanoscintillators

Advanced Functional Materials, EarlyView.
Lead halide perovskite nanocrystals are promising scintillators but suffer from reabsorption losses and limited compatibility with high‐Z additives. Hybridization of CsPbBr3 nanocrystals with PbBr2‐passivated HfO2 nanoparticle sensitizers, achieved during or after synthesis, produces stable composites with maintained optical quality, improved ...
Francesco Bruni, Saptarshi Chakraborty, Andrea Fratelli, Abdessamad El Adel, Jordi Llusar, Francesco Carulli, Matteo L. Zaffalon, Chenger Wang, Vojtech Zabloudil, Etiennette Auffray, Francesco Meinardi, Leonardo Poletti, Laura Lazzarini, Daniela Manno, Anna Galli, Francesca Rossi, Ivan Infante, Sergio Brovelli   +17 more
wiley   +1 more source

Pitfalls of Using the Cockcroft-Gault Formula When Calculating Carboplatin Dose for the Adjuvant Treatment of Patients with Stage i Seminoma

, 2012
Martin Fehr, T. Geldart, H.Y. Sun, PD Simmonds, Graham M. Mead, Matthew Wheater, N. Nagaraj, S. Ellis, Roger von Moos, Richard Cathomas   +9 more
openalex   +1 more source

A Single‐Metal‐Doped Nanoplatform for Ferroptosis‐Driven cGAS‐STING Pathway Activation in Hepatocellular Carcinoma Immunotherapy

Advanced Functional Materials, EarlyView.
The cGAS‐STING pathway boosts HCC antitumor immunity but lacks specific activation. Nanoplatform ZMRPF induces HCC ferroptosis via lipid ROS, releasing mtDNA. It synergizes with ZMRPF‐released Mn2⁺ to activate cGAS‐STING, amplifies antigen‐presenting cell activity, reverses HCC immunosuppression, and enables robust systemic antitumor immunity ...
Yuchen Zhang, Shuang Feng, Jie Luo, Kaige Xu, Junfeng Guo, Xingyue Zhang, Mengxue Yuan, Qiang Luo, Yu Huang, Chaoqiang Fan, Kibret Mequanint, Donghui Zhu, Malcolm Xing, Shiming Yang   +13 more
wiley   +1 more source

Actionable driver gene alterations in early-stage non-small cell lung cancer: a review. [PDF]

Ther Adv Med Oncol
Attili I, Pisapia P, Spitaleri G, Aliaga PT, Del Signore E, Napoli VM, Passaro A, Malapelle U, Troncone G, de Marinis F.   +9 more
europepmc   +1 more source

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF‐Mutated Melanoma

New England Journal of Medicine, 2017
G. Long, A. Hauschild, M. Santinami, V. Atkinson, M. Mandalà, V. Chiarion-Sileni, J. Larkin, M. Nyakas, C. Dutriaux, A. Haydon, C. Robert, L. Mortier, J. Schachter, D. Schadendorf, T. Lesimple, R. Plummer, R. Ji, Pingkuan Zhang, B. Mookerjee, J. Legos, R. Kefford, R. Dummer, J. Kirkwood   +22 more
semanticscholar   +1 more source